Amedisys, Inc.
AMED
Pozycja w akcjach
#4614
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Cena akcji
$100.99
Ostatnia synchronizacja: 2025-08-15
Kapitalizacja rynkowa
$3.31B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Amedisys, Inc. (AMED)
Kategoria
Healthcare
Marża operacyjna dla Amedisys, Inc. (AMED)
Marża operacyjna na dzień October 2026 TTM: 4.03%
Według najnowszych raportów finansowych i ceny akcji Amedisys, Inc., bieżąca marża operacyjna (TTM) wynosi 4.03%. Na koniec 2023 wynosiła 6.99%.
Historia marży operacyjnej dla Amedisys, Inc. od 2000 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 4.03% | 0.00% |
| 2024 | 4.03% | -42.35% |
| 2023 | 6.99% | -14.02% |
| 2022 | 8.13% | -28.56% |
| 2021 | 11.38% | 7.56% |
| 2020 | 10.58% | 16.65% |
| 2019 | 9.07% | -2.79% |
| 2018 | 9.33% | 82.23% |
| 2017 | 5.12% | 28.32% |
| 2016 | 3.99% | -654.17% |
| 2015 | -0.72% | -136.00% |
| 2014 | 2.00% | -116.13% |
| 2013 | -12.40% | 64.46% |
| 2012 | -7.54% | -76.45% |
| 2011 | -32.02% | -370.44% |
| 2010 | 11.84% | -22.36% |
| 2009 | 15.25% | 15.27% |
| 2008 | 13.23% | -4.41% |
| 2007 | 13.84% | 14.10% |
| 2006 | 12.13% | -7.62% |
| 2005 | 13.13% | -10.68% |
| 2004 | 14.70% | 46.12% |
| 2003 | 10.06% | 100.80% |
| 2002 | 5.01% | -26.00% |
| 2001 | 6.77% | 16,825.00% |
| 2000 | 0.04% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 15.48% | -96.16% |
US
|
|
| 0.00% | - |
DE
|
|
| 16.80% | -95.83% |
US
|
|
| 18.67% | -95.37% |
SA
|
|
| 0.00% | - |
MY
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.